首页 | 本学科首页   官方微博 | 高级检索  
     

立方液晶纳米粒在MDCK-MDR1细胞模型中的摄取及摄取机制研究
引用本文:谭宁,杜守颖,薛宇涛,谭丽,陆洋,李鹏跃. 立方液晶纳米粒在MDCK-MDR1细胞模型中的摄取及摄取机制研究[J]. 天津中医药, 2018, 35(1): 56-59
作者姓名:谭宁  杜守颖  薛宇涛  谭丽  陆洋  李鹏跃
作者单位:北京中医药大学中药学院, 中药药剂学研究室, 北京 100102,北京中医药大学中药学院, 中药药剂学研究室, 北京 100102,北京中医药大学中药学院, 中药药剂学研究室, 北京 100102,北京中医药大学中药学院, 中药药剂学研究室, 北京 100102,北京中医药大学中药学院, 中药药剂学研究室, 北京 100102,北京中医药大学中药学院, 中药药剂学研究室, 北京 100102
基金项目:北京市自然科学基金项目(7164274);2017年北京中医药大学研究生自主课题项目(2017-JYB-XS-072)。
摘    要:[目的]考察MDCK-MDR1细胞对立方液晶纳米粒的摄取及摄取机制。[方法]以钙黄绿素为标准荧光物质制备液晶纳米粒。采用流式细胞仪检测不同时间点MDCK-MDR1细胞内荧光强度,比较细胞对钙黄绿素、钙黄绿素液晶纳米粒摄取的差异;采用不同抑制剂(非律平、细胞松弛素D、氯丙嗪、2-D-去氧葡萄糖)与钙黄绿素液晶纳米粒共同孵育后,流式细胞仪测定胞内荧光强度,判断MDCK-MDR1细胞摄取液晶纳米粒的通路。[结果]摄取2 h内,立方液晶纳米粒不仅可以增加MDCK-MDR1细胞对钙黄绿素的摄取也可改变细胞的摄取行为。经氯丙嗪、2-D-去氧葡萄糖孵育的细胞胞内荧光含量低,差异有统计学意义(P0.05)。[结论]立方液晶纳米粒可增加MDCK-MDR1对钙黄绿素的摄取,摄取途径为能量依赖网格蛋白介导的主动内吞。

关 键 词:MDCK-MDR1  立方液晶纳米粒  摄取  机制  通路抑制剂
收稿时间:2017-07-26

Study on the cellular uptake and the up-take mechanism of cubic liquid crystalline nanoparticle on MDCK-MDR1 cells model
TAN Ning,DU Shouying,XUE Yutao,TAN Li,LU Yang and LI Pengyue. Study on the cellular uptake and the up-take mechanism of cubic liquid crystalline nanoparticle on MDCK-MDR1 cells model[J]. Tianjin Journal of Traditional Chin Medicine, 2018, 35(1): 56-59
Authors:TAN Ning  DU Shouying  XUE Yutao  TAN Li  LU Yang  LI Pengyue
Affiliation:School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing 100102, China,School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing 100102, China,School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing 100102, China,School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing 100102, China,School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing 100102, China and School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing 100102, China
Abstract:[Objective] To study cellular uptake and pathway of cubic liquid crystalline nanoparticles (LCNPs) on MDCK-MDR1 cells.[Methods] Make LCNPs with calein (Cal-LCNPs), the standard fluorescent substance. Fluorescence intensity in MDCK-MDR1 cells was measured by flow cytometry at different time points. Different inhibitors (Filipin, Phytoalexins D, 2-Deoxy-D-glucose, chlorpromazine) were incubated with Cal-LCNPs. Flow cytometry was used to determine the intracellular fluorescence intensity then determine the pathways.[Results] Cubic liquid crystal nanoparticles can not only increase the uptake of Cal in MDCK-MDR1 cells in 2h, but also alter the uptake behavior of cells. MDCK-MDR1 uptakes Cal was consistent with the zero-order equation, and Cal-LCNPs'' was in accordance with the first-order equation. The intracellular fluorescence of cells incubated with chlorpromazine and 2-D-deoxyglucose was low conpared with control (P<0.05).[Conclusion] Cubic liquid crystal nanoparticles can increase the uptake of calcein by MDCK-MDR1, and the pathway is energy-dependent clathrin mediated endocytosis initiative.
Keywords:MDCK-MDR1  LCNPs  uptake  mechanism  pathway inhibitor
本文献已被 CNKI 等数据库收录!
点击此处可从《天津中医药》浏览原始摘要信息
点击此处可从《天津中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号